Ocean Biomedical, Inc.

Ocean Biomedical, Inc. (ticker: OCEA) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of OCEA's SEC filings surfaces 9 active risk signals, including 6 late-filing signals, 2 delisting/deregistration signals, and 1 auditor-change signal. OCEA reported no tagged revenue in revenue and -$8.24M for the period ending 2025-03-31, with operating cash flow of -$356K. Cash and equivalents stood at $800K. Total assets of $1.58M are exceeded by total liabilities of $93.98M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.